Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Translational Medicine Centers
The University of California is expected to hear plans this summer by UC San Diego for a $110 million Center for Novel Therapeutics (CNT) designed to speed development of new treatments by the university and its industry partners. CNT is one of several efforts by academic institutions to draw industry into joint translational medicine efforts. The University of Florida is building a $45 million Clinical and Translational Research Building in Gainesville, while two Buckeye State schools, The Ohio State University and Ohio University, are launching a $35 million venture fund to finance translational projects.